(+)-dexrazoxane multiple interactions ISO RGD:1552456 6480464 [Doxorubicin co-treated with Dexrazoxane] results in decreased expression of BAK1 mRNA CTD PMID:26873546 (+)-Tetrandrine increases expression ISO RGD:1353034 6480464 tetrandrine results in increased expression of BAK1 protein CTD PMID:26822499 (-)-citrinin increases expression ISO RGD:1353034 6480464 Citrinin results in increased expression of BAK1 mRNA CTD PMID:30428381 (-)-citrinin multiple interactions ISO RGD:1353034 6480464 [Citrinin co-treated with ochratoxin A] results in decreased expression of BAK1 mRNA CTD PMID:30428381 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:1353034 6480464 epigallocatechin gallate results in decreased expression of BAK1 mRNA CTD PMID:18851785 (S)-(-)-perillyl alcohol increases expression ISO RGD:1353034 6480464 perillyl alcohol results in increased expression of BAK1 protein CTD PMID:12530055 (S)-amphetamine multiple interactions ISO RGD:1353034 6480464 [N-Methyl-3, 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in increased expression of BAK1 protein CTD PMID:23820845 (S)-amphetamine increases expression ISO RGD:1353034 6480464 Dextroamphetamine results in increased expression of BAK1 protein CTD PMID:23820845 (S)-naringenin increases expression ISO RGD:1353034 6480464 naringenin results in increased expression of BAK1 protein CTD PMID:27838343 1,1-dichloroethene increases expression ISO RGD:1552456 6480464 vinylidene chloride results in increased expression of BAK1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:1552456 6480464 1, 2-Dimethylhydrazine results in decreased expression of BAK1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1552456 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of BAK1 mRNA] CTD PMID:22206623 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of BAK1 mRNA CTD PMID:24140754 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of BAK1 mRNA CTD PMID:17557909 17beta-estradiol decreases expression ISO RGD:1353034 6480464 Estradiol results in decreased expression of BAK1 mRNA CTD PMID:23373633 1H-pyrazole multiple interactions EXP 6480464 [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAK1 mRNA CTD PMID:16610055 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:1353034 6480464 2 more ... CTD PMID:20638727 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1353034 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BAK1 mRNA CTD PMID:19520675 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552456 6480464 Tetrachlorodibenzodioxin affects the expression of BAK1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BAK1 mRNA CTD PMID:22298810 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 Losartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAK1 mRNA] CTD PMID:15502641 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of BAK1 mRNA CTD PMID:15502641 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1552456 6480464 tetrabromobisphenol A results in increased expression of BAK1 protein CTD PMID:27592553 3,4-methylenedioxymethamphetamine multiple interactions ISO RGD:1353034 6480464 [N-Methyl-3, 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in increased expression of BAK1 protein CTD PMID:23820845 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1353034 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of BAK1 protein CTD PMID:23820845 4,4'-diaminodiphenylmethane increases expression ISO RGD:1552456 6480464 4, 4'-diaminodiphenylmethane results in increased expression of BAK1 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide increases expression ISO RGD:1353034 6480464 Fenretinide results in increased expression of BAK1 protein CTD PMID:17273769 5-aza-2'-deoxycytidine increases expression ISO RGD:1353034 6480464 Decitabine results in increased expression of BAK1 mRNA CTD PMID:17908484 5-azacytidine multiple interactions EXP 6480464 [Azacitidine co-treated with entinostat] results in increased expression of BAK1 mRNA CTD PMID:21224363 5-azacytidine increases expression EXP 6480464 Azacitidine results in increased expression of BAK1 mRNA CTD PMID:21224363 5-fluorouracil increases expression ISO RGD:1353034 6480464 Fluorouracil results in increased expression of BAK1 more ... CTD PMID:15489892 more ... 5-fluorouracil multiple interactions ISO RGD:1353034 6480464 mithramycin A inhibits the reaction [Fluorouracil results in increased expression of BAK1 protein] CTD PMID:15489892 5-fluorouracil increases response to substance ISO RGD:1353034 6480464 BAK1 mRNA results in increased susceptibility to Fluorouracil CTD PMID:18593893 acetamide increases expression EXP 6480464 acetamide results in increased expression of BAK1 mRNA CTD PMID:31881176 acetochlor increases expression ISO RGD:1353034 6480464 acetochlor results in increased expression of BAK1 protein CTD PMID:25291404 acetylsalicylic acid increases expression ISO RGD:1353034 6480464 Aspirin results in increased expression of BAK1 protein CTD PMID:11532860 actinomycin D multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA] CTD PMID:21281706 actinomycin D multiple interactions ISO RGD:1552456 6480464 Dactinomycin promotes the reaction [BAK1 protein binds to BAK1 protein] CTD PMID:26670606 aflatoxin B1 increases expression ISO RGD:1353034 6480464 Aflatoxin B1 results in increased expression of BAK1 mRNA CTD PMID:22100608 alantolactone increases expression ISO RGD:1353034 6480464 alantolactone results in increased expression of BAK1 protein CTD PMID:22721982 aldehydo-D-glucose multiple interactions EXP 6480464 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA CTD PMID:29122578 aldehydo-D-glucose multiple interactions ISO RGD:1353034 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] CTD PMID:33962019 all-trans-retinoic acid multiple interactions ISO RGD:1353034 6480464 [Melatonin co-treated with Tretinoin] results in increased expression of BAK1 protein CTD PMID:10965999 all-trans-retinoic acid decreases expression ISO RGD:1353034 6480464 Tretinoin results in decreased expression of BAK1 mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:1353034 6480464 Tretinoin results in increased expression of BAK1 mRNA, Tretinoin results in increased expression of BAK1 protein CTD PMID:15498508 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BAK1 mRNA CTD PMID:16483693 anthocyanin multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Streptozocin results in increased expression of BAK1 protein] CTD PMID:28856781 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1353034 6480464 pyrazolanthrone inhibits the reaction [docetaxel results in increased activity of BAK1 protein] CTD PMID:17317842 antirheumatic drug decreases expression ISO RGD:1353034 6480464 Antirheumatic Agents results in decreased expression of BAK1 mRNA CTD PMID:24449571 arecoline increases expression EXP 6480464 Arecoline results in increased expression of BAK1 protein CTD PMID:33929070 aristolochic acid increases expression ISO RGD:1353034 6480464 aristolochic acid I results in increased expression of BAK1 mRNA CTD PMID:33212167 arsenite(3-) increases activity ISO RGD:1353034 6480464 arsenite results in increased activity of BAK1 protein CTD PMID:17553788 arsenite(3-) increases expression ISO RGD:1552456 6480464 arsenite results in increased expression of BAK1 mRNA CTD PMID:33053406 arsenous acid decreases expression ISO RGD:1353034 6480464 Arsenic Trioxide results in decreased expression of BAK1 mRNA CTD PMID:11940349 , PMID:17530438 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BAK1 mRNA CTD PMID:19730151 arsenous acid increases expression ISO RGD:1552456 6480464 Arsenic Trioxide results in increased expression of BAK1 mRNA CTD PMID:21533816 arsenous acid multiple interactions ISO RGD:1552456 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of BAK1 mRNA] more ... CTD PMID:21533816 , PMID:28587418 arsenous acid increases expression ISO RGD:1353034 6480464 Arsenic Trioxide results in increased expression of BAK1 protein CTD PMID:19695276 more ... arsenous acid affects response to substance ISO RGD:1552456 6480464 BAK1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:15979664 arsenous acid multiple interactions ISO RGD:1353034 6480464 [Arsenic Trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BAK1 protein CTD PMID:24126434 atorvastatin calcium increases expression ISO RGD:1353034 6480464 Atorvastatin results in increased expression of BAK1 protein CTD PMID:19935899 auranofin multiple interactions ISO RGD:1552456 6480464 [BAX co-treated with BAK1] results in increased susceptibility to Auranofin, BAK1 mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] CTD PMID:18789312 , PMID:21172426 auranofin increases response to substance ISO RGD:1552456 6480464 BAK1 results in increased susceptibility to Auranofin CTD PMID:18789312 benzo[a]pyrene decreases methylation ISO RGD:1353034 6480464 Benzo(a)pyrene results in decreased methylation of BAK1 promoter CTD PMID:27901495 betulinic acid increases expression ISO RGD:1353034 6480464 betulinic acid results in increased expression of BAK1 protein CTD PMID:33181113 betulinic acid multiple interactions ISO RGD:1353034 6480464 [betulinic acid co-treated with Oxygen deficiency] results in increased expression of BAK1 protein CTD PMID:33181113 bisphenol A decreases expression ISO RGD:1353034 6480464 bisphenol A results in decreased expression of BAK1 protein CTD PMID:21277958 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BAK1 mRNA CTD PMID:30816183 , PMID:33296240 bisphenol A increases expression ISO RGD:1552456 6480464 bisphenol A results in increased expression of BAK1 mRNA CTD PMID:31453682 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BAK1 mRNA CTD PMID:25181051 , PMID:27296223 bisphenol F increases expression ISO RGD:1552456 6480464 bisphenol F results in increased expression of BAK1 mRNA CTD PMID:31453682 bortezomib multiple interactions ISO RGD:1353034 6480464 [nutlin 3 co-treated with Bortezomib] results in increased activity of BAK1 protein, BAK1 affects the reaction [Bortezomib results in increased susceptibility to and results in increased activity of TNFSF10 protein] CTD PMID:17326159 , PMID:20850924 bortezomib multiple interactions ISO RGD:1552456 6480464 BAK1 protein results in increased susceptibility to [Bortezomib co-treated with TNFSF10 protein] CTD PMID:12902978 bortezomib increases expression ISO RGD:1353034 6480464 Bortezomib results in increased expression of BAK1 protein CTD PMID:17326159 Brusatol increases expression ISO RGD:1353034 6480464 brusatol results in increased expression of BAK1 protein CTD PMID:33465425 butanal increases expression ISO RGD:1353034 6480464 butyraldehyde results in increased expression of BAK1 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:1353034 6480464 Acetylcysteine inhibits the reaction [Cadmium results in increased expression of BAK1] CTD PMID:23339468 cadmium atom increases expression ISO RGD:1353034 6480464 Cadmium results in increased expression of BAK1 CTD PMID:23339468 cadmium sulfide decreases expression ISO RGD:1353034 6480464 cadmium sulfide results in decreased expression of BAK1 mRNA CTD PMID:27866839 camptothecin decreases expression ISO RGD:1353034 6480464 Camptothecin results in decreased expression of BAK1 mRNA CTD PMID:30581319 camptothecin multiple interactions ISO RGD:1353034 6480464 Folic Acid inhibits the reaction [Camptothecin results in decreased expression of BAK1 mRNA] CTD PMID:30581319 capsaicin increases activity ISO RGD:1552456 6480464 Capsaicin results in increased activity of BAK1 protein CTD PMID:17295509 capsaicin increases expression ISO RGD:1353034 6480464 Capsaicin results in increased expression of BAK1 mRNA CTD PMID:19502594 carbon nanotube increases expression ISO RGD:1552456 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1353034 6480464 Nanotubes, Carbon results in increased expression of BAK1 mRNA CTD PMID:15585362 carvedilol multiple interactions EXP 6480464 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA CTD PMID:29122578 casticin increases expression ISO RGD:1353034 6480464 casticin results in increased expression of BAK1 protein CTD PMID:27862857 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of BAK1 mRNA CTD PMID:18500788 celecoxib increases expression ISO RGD:1353034 6480464 Celecoxib analog results in increased expression of BAK1 protein more ... CTD PMID:19428934 , PMID:19682443 celecoxib decreases response to substance EXP 6480464 BAK1 results in decreased susceptibility to Celecoxib CTD PMID:18349538 chrysophanol increases expression ISO RGD:1353034 6480464 chrysophanic acid results in increased expression of BAK1 protein CTD PMID:30300626 cisplatin multiple interactions ISO RGD:1552456 6480464 [BAX co-treated with BAK1] results in increased susceptibility to Cisplatin, [SLC39A8 protein results in increased susceptibility to Cisplatin] which results in increased expression of BAK1 protein CTD PMID:21172426 , PMID:30342059 cisplatin increases expression ISO RGD:1353034 6480464 Cisplatin results in increased expression of BAK1 mRNA, Cisplatin results in increased expression of BAK1 protein CTD PMID:11099651 more ... cisplatin increases response to substance ISO RGD:1353034 6480464 BAK1 protein results in increased susceptibility to Cisplatin CTD PMID:17688235 cisplatin multiple interactions ISO RGD:1353034 6480464 [Cisplatin co-treated with fisetin] results in increased expression of BAK1 protein more ... CTD PMID:21052098 more ... coenzyme Q10 multiple interactions EXP 6480464 coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of BAK1 protein] CTD PMID:27087047 copper atom multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA more ... CTD PMID:22085843 copper(0) multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA more ... CTD PMID:22085843 coumarin increases expression ISO RGD:1353034 6480464 coumarin analog results in increased expression of BAK1 protein CTD PMID:31199928 curcumin multiple interactions ISO RGD:1353034 6480464 TNFSF10 protein promotes the reaction [Curcumin results in increased expression of BAK1 protein] CTD PMID:18226269 curcumin decreases expression ISO RGD:1353034 6480464 Curcumin results in decreased expression of BAK1 mRNA CTD PMID:33582110 curcumin increases expression ISO RGD:1353034 6480464 Curcumin results in increased expression of BAK1 mRNA, Curcumin results in increased expression of BAK1 protein CTD PMID:17332930 , PMID:18226269 curcumin increases response to substance ISO RGD:1552456 6480464 BAK1 protein results in increased susceptibility to Curcumin CTD PMID:17277231 curcumin increases expression ISO RGD:1552456 6480464 Curcumin results in increased expression of BAK1 protein CTD PMID:17277231 cylindrospermopsin increases expression ISO RGD:1353034 6480464 cylindrospermopsin results in increased expression of BAK1 mRNA CTD PMID:23726867 D-glucose multiple interactions EXP 6480464 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA CTD PMID:29122578 D-glucose multiple interactions ISO RGD:1353034 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] CTD PMID:33962019 DDE multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA] CTD PMID:21281706 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA CTD PMID:21281706 , PMID:21384494 deguelin increases expression ISO RGD:1353034 6480464 deguelin results in increased expression of BAK1 protein CTD PMID:26592500 delphinidin increases expression ISO RGD:1353034 6480464 delphinidin results in increased expression of BAK1 protein CTD PMID:29451351 demethoxycurcumin decreases expression ISO RGD:1353034 6480464 demethoxycurcumin results in decreased expression of BAK1 mRNA CTD PMID:33582110 deoxynivalenol increases expression ISO RGD:1353034 6480464 deoxynivalenol results in increased expression of BAK1 mRNA CTD PMID:20702593 desferrioxamine B multiple interactions ISO RGD:1353034 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] CTD PMID:33962019 Destruxin B multiple interactions ISO RGD:1353034 6480464 Sorafenib promotes the reaction [destruxin B results in increased expression of BAK1 protein] CTD PMID:24434019 Destruxin B increases expression ISO RGD:1353034 6480464 destruxin B results in increased expression of BAK1 protein CTD PMID:24434019 dexamethasone increases expression ISO RGD:1353034 6480464 Dexamethasone results in increased expression of BAK1 mRNA, Dexamethasone results in increased expression of BAK1 protein CTD PMID:19428934 dexamethasone multiple interactions EXP 6480464 fludarabine inhibits the reaction [Dexamethasone results in increased expression of BAK1 protein] CTD PMID:30506661 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of BAK1 protein CTD PMID:30506661 diallyl trisulfide increases expression ISO RGD:1353034 6480464 diallyl trisulfide results in increased expression of BAK1 protein CTD PMID:17513609 diallyl trisulfide multiple interactions ISO RGD:1353034 6480464 SOD2 protein inhibits the reaction [diallyl trisulfide results in increased activity of BAK1 protein] CTD PMID:23412769 diallyl trisulfide increases activity ISO RGD:1353034 6480464 diallyl trisulfide results in increased activity of BAK1 protein CTD PMID:23412769 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BAK1 mRNA CTD PMID:19730151 diarsenic trioxide increases expression ISO RGD:1552456 6480464 Arsenic Trioxide results in increased expression of BAK1 mRNA CTD PMID:21533816 diarsenic trioxide multiple interactions ISO RGD:1552456 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of BAK1 mRNA] more ... CTD PMID:21533816 , PMID:28587418 diarsenic trioxide affects response to substance ISO RGD:1552456 6480464 BAK1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:15979664 diarsenic trioxide multiple interactions ISO RGD:1353034 6480464 [Arsenic Trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BAK1 protein CTD PMID:24126434 diarsenic trioxide increases expression ISO RGD:1353034 6480464 Arsenic Trioxide results in increased expression of BAK1 protein CTD PMID:19695276 more ... diarsenic trioxide decreases expression ISO RGD:1353034 6480464 Arsenic Trioxide results in decreased expression of BAK1 mRNA CTD PMID:11940349 , PMID:17530438 diazinon affects expression EXP 6480464 Diazinon affects the expression of BAK1 mRNA CTD PMID:22546817 diclofenac increases activity ISO RGD:1353034 6480464 Diclofenac results in increased activity of BAK1 protein CTD PMID:18191430 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of BAK1 mRNA CTD PMID:22546817 diepoxybutane increases expression ISO RGD:1353034 6480464 diepoxybutane results in increased expression of BAK1, diepoxybutane results in increased expression of BAK1 mRNA CTD PMID:17693053 , PMID:29792945 dioscin multiple interactions ISO RGD:1552456 6480464 dioscin inhibits the reaction [Acetaminophen results in increased expression of BAK1 protein] CTD PMID:22939915 dioscin increases expression ISO RGD:1353034 6480464 dioscin results in increased expression of BAK1 mRNA, dioscin results in increased expression of BAK1 protein CTD PMID:22334414 more ... dioxygen multiple interactions EXP 6480464 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA CTD PMID:29122578 dioxygen multiple interactions ISO RGD:1353034 6480464 [betulinic acid co-treated with Oxygen deficiency] results in increased expression of BAK1 protein CTD PMID:33181113 disodium selenite increases expression ISO RGD:1353034 6480464 Sodium Selenite results in increased expression of BAK1 mRNA CTD PMID:16705456 disulfiram multiple interactions ISO RGD:1353034 6480464 [arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BAK1 protein CTD PMID:24126434 doxorubicin decreases response to substance ISO RGD:1353034 6480464 BAK1 protein results in decreased susceptibility to Doxorubicin CTD PMID:11313874 doxorubicin decreases expression ISO RGD:1353034 6480464 Doxorubicin results in decreased expression of BAK1 mRNA CTD PMID:30581319 doxorubicin multiple interactions EXP 6480464 coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of BAK1 protein] CTD PMID:27087047 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of BAK1 protein CTD PMID:27087047 , PMID:30009776 doxorubicin increases expression ISO RGD:1552456 6480464 Doxorubicin results in increased expression of BAK1 mRNA CTD PMID:26873546 doxorubicin multiple interactions ISO RGD:1552456 6480464 [Doxorubicin co-treated with Dexrazoxane] results in decreased expression of BAK1 mRNA CTD PMID:26873546 doxorubicin increases expression ISO RGD:1353034 6480464 Doxorubicin results in increased expression of BAK1 mRNA, Doxorubicin results in increased expression of BAK1 protein CTD PMID:20856197 , PMID:29803840 doxorubicin increases response to substance ISO RGD:1353034 6480464 BAK1 protein results in increased susceptibility to Doxorubicin CTD PMID:17688235 doxorubicin increases activity ISO RGD:1353034 6480464 Doxorubicin results in increased activity of BAK1 protein CTD PMID:15917298 doxorubicin multiple interactions ISO RGD:1353034 6480464 BAK1 protein results in increased susceptibility to [Doxorubicin co-treated with PI103] more ... CTD PMID:15917298 more ... entinostat multiple interactions EXP 6480464 [Azacitidine co-treated with entinostat] results in increased expression of BAK1 mRNA CTD PMID:21224363 entinostat increases expression ISO RGD:1552456 6480464 entinostat results in increased expression of BAK1 protein CTD PMID:21041383 epichlorohydrin increases expression ISO RGD:1353034 6480464 Epichlorohydrin results in increased expression of BAK1 mRNA CTD PMID:29792945 esculetin increases expression ISO RGD:1353034 6480464 esculetin results in increased expression of BAK1 protein CTD PMID:26388407 ethanol multiple interactions EXP 6480464 [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAK1 mRNA CTD PMID:16610055 ethanol increases expression ISO RGD:1552456 6480464 Ethanol results in increased expression of BAK1 protein CTD PMID:27270636 ethanol multiple interactions ISO RGD:1552456 6480464 SIAH1 protein promotes the reaction [Ethanol results in increased expression of BAK1 protein] CTD PMID:27270636 ethyl methanesulfonate increases expression ISO RGD:1353034 6480464 Ethyl Methanesulfonate results in increased expression of BAK1 mRNA CTD PMID:23649840 etoposide increases activity ISO RGD:1353034 6480464 Etoposide results in increased activity of BAK1 protein CTD PMID:21745461 etoposide increases response to substance ISO RGD:1353034 6480464 BAK1 protein results in increased susceptibility to Etoposide CTD PMID:17688235 etoposide affects response to substance ISO RGD:1552456 6480464 BAK1 protein affects the susceptibility to Etoposide CTD PMID:16077961 etoposide multiple interactions ISO RGD:1353034 6480464 nimesulide inhibits the reaction [Etoposide results in increased activity of BAK1 protein] CTD PMID:21745461 etoposide affects expression ISO RGD:1353034 6480464 Etoposide affects the expression of BAK1 protein CTD PMID:15215046 farnesol increases expression ISO RGD:1353034 6480464 Farnesol results in increased expression of BAK1 protein CTD PMID:12530055 fisetin multiple interactions ISO RGD:1353034 6480464 [Cisplatin co-treated with fisetin] results in increased expression of BAK1 protein CTD PMID:21216935 flavonoids multiple interactions ISO RGD:1552456 6480464 Flavonoids inhibits the reaction [Carbon Tetrachloride results in increased expression of BAK1 protein] CTD PMID:23279844 flufenamic acid multiple interactions ISO RGD:1353034 6480464 Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein] CTD PMID:27957685 flufenoxuron increases expression ISO RGD:1552456 6480464 flufenoxuron results in increased expression of BAK1 protein CTD PMID:33771252 folic acid multiple interactions ISO RGD:1552456 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of BAK1 mRNA] CTD PMID:22206623 folic acid multiple interactions ISO RGD:1353034 6480464 Folic Acid inhibits the reaction [Camptothecin results in decreased expression of BAK1 mRNA] more ... CTD PMID:30581319 fonofos increases methylation ISO RGD:1353034 6480464 Fonofos results in increased methylation of BAK1 promoter CTD PMID:22847954 furan increases expression EXP 6480464 furan results in increased expression of BAK1 mRNA CTD PMID:22079235 , PMID:26194646 furosemide affects expression EXP 6480464 Furosemide affects the expression of BAK1 mRNA CTD PMID:17497460 genistein multiple interactions ISO RGD:1353034 6480464 [ASRGL1 protein co-treated with Genistein] results in increased expression of BAK1 protein CTD PMID:33347704 genistein increases expression ISO RGD:1353034 6480464 Genistein results in increased expression of BAK1 protein CTD PMID:33347704 geraniol increases expression ISO RGD:1353034 6480464 geraniol results in increased expression of BAK1 protein CTD PMID:12530055 glucose multiple interactions EXP 6480464 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA CTD PMID:29122578 glucose multiple interactions ISO RGD:1353034 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] CTD PMID:33962019 gold atom increases expression ISO RGD:1353034 6480464 Gold results in increased expression of BAK1 mRNA CTD PMID:22178767 gold(0) increases expression ISO RGD:1353034 6480464 Gold results in increased expression of BAK1 mRNA CTD PMID:22178767 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of BAK1 protein CTD PMID:14505808 hydrogen peroxide decreases expression ISO RGD:1353034 6480464 Hydrogen Peroxide results in decreased expression of BAK1 mRNA CTD PMID:12419474 hydrogen peroxide multiple interactions EXP 6480464 Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of BAK1 protein] CTD PMID:14505808 hyperforin increases expression ISO RGD:1353034 6480464 hyperforin results in increased expression of BAK1 protein CTD PMID:32485087 indometacin increases expression ISO RGD:1353034 6480464 Indomethacin results in increased expression of BAK1 protein CTD PMID:11532860 indometacin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Indomethacin results in increased expression of BAK1 mRNA] CTD PMID:19220725 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of BAK1 mRNA CTD PMID:19220725 iohexol increases expression ISO RGD:1353034 6480464 Iohexol results in increased expression of BAK1 mRNA CTD PMID:29705293 iopamidol increases expression ISO RGD:1353034 6480464 Iopamidol results in increased expression of BAK1 mRNA CTD PMID:29705293 isoflurane decreases expression EXP 6480464 Isoflurane results in decreased expression of BAK1 mRNA CTD PMID:16978161 isoprenaline decreases expression ISO RGD:1353034 6480464 Isoproterenol results in decreased expression of BAK1 mRNA CTD PMID:24286936 ivermectin decreases expression ISO RGD:1353034 6480464 Ivermectin results in decreased expression of BAK1 protein CTD PMID:32959892 L-ascorbic acid multiple interactions ISO RGD:1353034 6480464 [arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BAK1 protein CTD PMID:24126434 levamisole increases expression ISO RGD:1353034 6480464 Levamisole results in increased expression of BAK1 protein CTD PMID:11139434 LGK974 multiple interactions ISO RGD:1353034 6480464 LGK974 inhibits the reaction [Paraquat results in increased expression of BAK1 protein] CTD PMID:30205152 Licochalcone A increases expression ISO RGD:1353034 6480464 licochalcone A results in increased expression of BAK1 mRNA CTD PMID:30055311 linalool increases expression ISO RGD:1353034 6480464 linalool results in increased expression of BAK1 mRNA CTD PMID:28567457 lithocholic acid multiple interactions ISO RGD:1552456 6480464 [Lithocholic Acid co-treated with 1 more ... CTD PMID:19433268 losartan multiple interactions EXP 6480464 Losartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAK1 mRNA] CTD PMID:15502641 Luteolin 7-methyl ether increases expression EXP 6480464 hydroxygenkwanin results in increased expression of BAK1 protein CTD PMID:24144774 maneb multiple interactions ISO RGD:1552456 6480464 [Maneb co-treated with Paraquat] results in increased expression of BAK1 mRNA more ... CTD PMID:23963992 maneb multiple interactions ISO RGD:1353034 6480464 [Paraquat co-treated with Maneb] results in increased expression of BAK1 protein more ... CTD PMID:18266926 maneb increases expression ISO RGD:1353034 6480464 Maneb results in increased expression of BAK1 mRNA, Maneb results in increased expression of BAK1 protein CTD PMID:18266926 maneb affects response to substance ISO RGD:1353034 6480464 BAK1 protein affects the susceptibility to Maneb CTD PMID:18266926 mechlorethamine increases expression ISO RGD:1353034 6480464 Mechlorethamine results in increased expression of BAK1 protein CTD PMID:22285227 melatonin multiple interactions ISO RGD:1353034 6480464 [Melatonin co-treated with Tretinoin] results in increased expression of BAK1 protein, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] CTD PMID:10965999 , PMID:33962019 melatonin multiple interactions ISO RGD:1552456 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of BAK1 mRNA] CTD PMID:23963992 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Indomethacin results in increased expression of BAK1 mRNA] CTD PMID:19220725 melittin increases expression ISO RGD:1353034 6480464 Melitten results in increased expression of BAK1 protein CTD PMID:34375656 melphalan increases expression ISO RGD:1353034 6480464 Melphalan results in increased expression of BAK1 protein CTD PMID:22285227 menadione affects expression ISO RGD:1353034 6480464 Vitamin K 3 affects the expression of BAK1 mRNA CTD PMID:20044591 methamphetamine multiple interactions ISO RGD:1353034 6480464 [N-Methyl-3, 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in increased expression of BAK1 protein CTD PMID:23820845 methamphetamine increases expression ISO RGD:1353034 6480464 Methamphetamine results in increased expression of BAK1 protein CTD PMID:23820845 methotrexate increases expression ISO RGD:1353034 6480464 Methotrexate results in increased expression of BAK1 mRNA CTD PMID:21678067 methoxyacetic acid affects expression EXP 6480464 methoxyacetic acid affects the expression of BAK1 protein CTD PMID:10809232 methyl methanesulfonate increases expression ISO RGD:1353034 6480464 Methyl Methanesulfonate results in increased expression of BAK1 mRNA CTD PMID:23649840 , PMID:30581319 methyl methanesulfonate multiple interactions ISO RGD:1353034 6480464 Folic Acid inhibits the reaction [Methyl Methanesulfonate results in increased expression of BAK1 mRNA] CTD PMID:30581319 minocycline multiple interactions EXP 6480464 [Minocycline results in increased expression of BCL2 protein] which binds to BAK1 protein CTD PMID:15004018 Mitotane increases expression EXP 6480464 Mitotane results in increased expression of BAK1 mRNA CTD PMID:23485034 MK-2206 multiple interactions ISO RGD:1353034 6480464 [mirdametinib co-treated with MK 2206] results in increased expression of BAK1 protein more ... CTD PMID:27634878 morphine increases expression ISO RGD:1353034 6480464 Morphine results in increased expression of BAK1 protein CTD PMID:19070643 mycophenolic acid increases expression ISO RGD:1353034 6480464 Mycophenolic Acid results in increased expression of BAK1 protein CTD PMID:16505121 Myrtucommulone A decreases expression ISO RGD:1552456 6480464 myrtucommulone A results in decreased expression of BAK1 mRNA CTD PMID:26032814 N-acetyl-L-cysteine multiple interactions ISO RGD:1552456 6480464 Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of BAK1 mRNA], Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of BAK1 mRNA] CTD PMID:21533816 , PMID:21549813 N-acetyl-L-cysteine multiple interactions ISO RGD:1353034 6480464 Acetylcysteine inhibits the reaction [Cadmium results in increased expression of BAK1] CTD PMID:23339468 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA] more ... CTD PMID:22085843 , PMID:28296042 N-methyl-4-phenylpyridinium increases expression ISO RGD:1353034 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BAK1 mRNA, 1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein CTD PMID:18266926 , PMID:27957685 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1353034 6480464 Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein], TRPM2 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein] CTD PMID:27957685 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:1353034 6480464 BAK1 protein results in increased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] CTD PMID:18376143 N-nitrosodiethylamine multiple interactions EXP 6480464 3 more ... CTD PMID:27048571 navitoclax multiple interactions ISO RGD:1353034 6480464 [navitoclax co-treated with Vorinostat] affects the activity of BAK1 protein CTD PMID:21652541 nickel atom increases expression ISO RGD:1353034 6480464 Nickel results in increased expression of BAK1 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride increases expression EXP 6480464 nickel chloride results in increased expression of BAK1 mRNA CTD PMID:21843586 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of BAK1 mRNA CTD PMID:22546817 nickel sulfate multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of BAK1 mRNA] more ... CTD PMID:28296042 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of BAK1 mRNA, nickel sulfate results in increased expression of BAK1 protein CTD PMID:28296042 niclosamide multiple interactions ISO RGD:1353034 6480464 [Niclosamide binds to Polyethyleneimine] which results in increased expression of BAK1 mRNA CTD PMID:25988281 nimesulide multiple interactions ISO RGD:1353034 6480464 nimesulide inhibits the reaction [Etoposide results in increased activity of BAK1 protein] CTD PMID:21745461 nimesulide decreases response to substance EXP 6480464 BAK1 results in decreased susceptibility to nimesulide CTD PMID:18349538 Nutlin-3 multiple interactions ISO RGD:1353034 6480464 [nutlin 3 co-treated with Bortezomib] results in increased activity of BAK1 protein CTD PMID:20850924 ochratoxin A decreases expression ISO RGD:1353034 6480464 ochratoxin A results in decreased expression of BAK1 mRNA, ochratoxin A results in decreased expression of BAK1 protein CTD PMID:19367635 , PMID:30428381 ochratoxin A multiple interactions ISO RGD:1353034 6480464 [Citrinin co-treated with ochratoxin A] results in decreased expression of BAK1 mRNA CTD PMID:30428381 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of BAK1 mRNA CTD PMID:23358140 okadaic acid increases expression ISO RGD:1353034 6480464 Okadaic Acid results in increased expression of BAK1 mRNA CTD PMID:31926150 osthole increases expression ISO RGD:1353034 6480464 osthol results in increased expression of BAK1 protein CTD PMID:29319219 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of BAK1 mRNA, oxybenzone results in increased expression of BAK1 protein CTD PMID:30099065 , PMID:30316929 p-menthan-3-ol increases expression ISO RGD:1353034 6480464 Menthol results in increased expression of BAK1 mRNA CTD PMID:26760959 paclitaxel affects expression ISO RGD:1353034 6480464 Paclitaxel affects the expression of BAK1 mRNA, Paclitaxel affects the expression of BAK1 protein CTD PMID:10822281 paclitaxel increases expression ISO RGD:1353034 6480464 Paclitaxel results in increased expression of BAK1 mRNA, Paclitaxel results in increased expression of BAK1 protein CTD PMID:10822281 , PMID:24126434 paclitaxel multiple interactions ISO RGD:1552456 6480464 [BAK1 protein mutant form co-treated with BAX protein mutant form] inhibits the reaction [Paclitaxel results in increased activity of and results in increased cleavage of CASP3 protein] CTD PMID:17652622 paclitaxel increases response to substance ISO RGD:1353034 6480464 BAK1 protein results in increased susceptibility to Paclitaxel CTD PMID:17688235 paracetamol affects expression ISO RGD:1552456 6480464 Acetaminophen affects the expression of BAK1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of BAK1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1353034 6480464 Acetaminophen results in increased expression of BAK1 mRNA CTD PMID:27761495 paracetamol multiple interactions ISO RGD:1552456 6480464 dioscin inhibits the reaction [Acetaminophen results in increased expression of BAK1 protein] CTD PMID:22939915 paracetamol increases expression ISO RGD:1552456 6480464 Acetaminophen results in increased expression of BAK1 protein CTD PMID:22939915 paraquat increases expression ISO RGD:1353034 6480464 Paraquat results in increased expression of BAK1 mRNA, Paraquat results in increased expression of BAK1 protein CTD PMID:18056701 more ... paraquat increases expression ISO RGD:1552456 6480464 Paraquat results in increased expression of BAK1 protein CTD PMID:18056701 paraquat multiple interactions ISO RGD:1353034 6480464 [Paraquat co-treated with Maneb] results in increased expression of BAK1 protein more ... CTD PMID:18266926 , PMID:30205152 paraquat affects response to substance ISO RGD:1353034 6480464 BAK1 protein affects the susceptibility to Paraquat CTD PMID:18056701 , PMID:18266926 paraquat multiple interactions ISO RGD:1552456 6480464 [Maneb co-treated with Paraquat] results in increased expression of BAK1 mRNA more ... CTD PMID:23963992 paraquat decreases expression ISO RGD:1353034 6480464 Paraquat results in decreased expression of BAK1 mRNA CTD PMID:18836921 paraquat multiple interactions EXP 6480464 NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of BAK1 mRNA], Paraquat promotes the reaction [BAX protein binds to BAK1 protein] CTD PMID:22678742 , PMID:25947082 paraquat increases expression EXP 6480464 Paraquat results in increased expression of BAK1 mRNA, Paraquat results in increased expression of BAK1 protein CTD PMID:22678742 parathion increases methylation ISO RGD:1353034 6480464 Parathion results in increased methylation of BAK1 promoter CTD PMID:22847954 parthenolide increases expression ISO RGD:1353034 6480464 parthenolide results in increased expression of BAK1 protein CTD PMID:16024633 PD 0325901 multiple interactions ISO RGD:1353034 6480464 [mirdametinib co-treated with MK 2206] results in increased expression of BAK1 protein more ... CTD PMID:27634878 PD 0325901 increases expression ISO RGD:1353034 6480464 mirdametinib results in increased expression of BAK1 protein CTD PMID:27634878 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1353034 6480464 perfluorooctane sulfonic acid results in decreased expression of BAK1 mRNA CTD PMID:32790152 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1353034 6480464 perfluorooctane sulfonic acid promotes the reaction [BAX protein binds to BAK1 protein] CTD PMID:34006824 perfluorooctanoic acid decreases expression ISO RGD:1353034 6480464 perfluorooctanoic acid results in decreased expression of BAK1 mRNA CTD PMID:32790152 perifosine multiple interactions ISO RGD:1353034 6480464 [perifosine co-treated with Butyrates] results in decreased expression of BAK1 protein more ... CTD PMID:15781658 perillyl alcohol increases expression ISO RGD:1353034 6480464 perillyl alcohol results in increased expression of BAK1 protein CTD PMID:12530055 phenobarbital multiple interactions ISO RGD:1552456 6480464 [Lithocholic Acid co-treated with Phenobarbital] results in decreased expression of BAK1 protein CTD PMID:19433268 phenobarbital multiple interactions EXP 6480464 3 more ... CTD PMID:27048571 phorbol 13-acetate 12-myristate increases expression ISO RGD:1353034 6480464 Tetradecanoylphorbol Acetate results in increased expression of BAK1 protein CTD PMID:11139146 platycodin D increases expression ISO RGD:1353034 6480464 platycodin D results in increased expression of BAK1 protein CTD PMID:23236765 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:1552456 6480464 [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of BAK1 protein CTD PMID:19433268 promethazine increases expression ISO RGD:1353034 6480464 Promethazine results in increased expression of BAK1 protein CTD PMID:31682805 propylparaben increases expression ISO RGD:1353034 6480464 propylparaben results in increased expression of BAK1 mRNA CTD PMID:24481588 prostaglandin E2 multiple interactions ISO RGD:1552456 6480464 Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BAK1 protein]] CTD PMID:25432964 pterostilbene increases expression ISO RGD:1353034 6480464 pterostilbene results in increased expression of BAK1 protein CTD PMID:23313376 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA more ... CTD PMID:22085843 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of BAK1 protein] CTD PMID:14505808 quercetin increases expression ISO RGD:1353034 6480464 Quercetin metabolite results in increased expression of BAK1 protein, Quercetin results in increased expression of BAK1 protein CTD PMID:16280456 more ... quercetin increases expression ISO RGD:1552456 6480464 Quercetin results in increased expression of BAK1 protein CTD PMID:17039455 raloxifene decreases expression ISO RGD:1353034 6480464 Raloxifene Hydrochloride results in decreased expression of BAK1 mRNA CTD PMID:16202921 resveratrol multiple interactions ISO RGD:1353034 6480464 [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAK1 protein] more ... CTD PMID:12902349 more ... resveratrol increases activity ISO RGD:1353034 6480464 resveratrol results in increased activity of BAK1 protein CTD PMID:22245142 , PMID:22644961 resveratrol increases response to substance ISO RGD:1353034 6480464 BAK1 protein results in increased susceptibility to resveratrol CTD PMID:16550006 , PMID:22245142 resveratrol increases expression ISO RGD:1353034 6480464 resveratrol results in increased expression of BAK1 mRNA, resveratrol results in increased expression of BAK1 protein CTD PMID:12002526 more ... resveratrol affects folding ISO RGD:1353034 6480464 resveratrol affects the folding of BAK1 protein CTD PMID:16617056 ritonavir increases expression ISO RGD:1353034 6480464 Ritonavir results in increased expression of BAK1 protein CTD PMID:19386116 romidepsin multiple interactions ISO RGD:1353034 6480464 [romidepsin co-treated with mirdametinib co-treated with MK 2206] results in increased expression of BAK1 protein more ... CTD PMID:27634878 romidepsin increases expression ISO RGD:1353034 6480464 romidepsin results in increased expression of BAK1 protein CTD PMID:27634878 rottlerin multiple interactions ISO RGD:1353034 6480464 rottlerin inhibits the reaction [Doxorubicin results in increased activity of BAK1 protein] CTD PMID:15917298 SB 203580 multiple interactions ISO RGD:1353034 6480464 SB 203580 inhibits the reaction [Sulindac affects the localization of BAK1 protein] CTD PMID:17136320 Se-methyl-L-selenocysteine increases expression ISO RGD:1353034 6480464 selenomethylselenocysteine metabolite results in increased expression of BAK1 mRNA CTD PMID:25321483 Se-methylselenocysteine increases expression ISO RGD:1353034 6480464 selenomethylselenocysteine metabolite results in increased expression of BAK1 mRNA CTD PMID:25321483 sodium arsenite decreases expression ISO RGD:1552456 6480464 sodium arsenite results in decreased expression of BAK1 mRNA CTD PMID:16014739 sorafenib multiple interactions ISO RGD:1353034 6480464 [sorafenib co-treated with TNFSF10 protein] affects the folding of and results in increased activity of BAK1 protein more ... CTD PMID:17909059 , PMID:24434019 sorafenib increases expression ISO RGD:1353034 6480464 sorafenib results in increased expression of BAK1 protein CTD PMID:18200035 sorafenib decreases expression ISO RGD:1353034 6480464 sorafenib results in decreased expression of BAK1 protein CTD PMID:16109713 streptozocin multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Streptozocin results in increased expression of BAK1 protein] CTD PMID:28856781 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of BAK1 protein CTD PMID:28856781 succimer multiple interactions ISO RGD:1552456 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAK1 mRNA CTD PMID:26378955 sulindac affects localization ISO RGD:1353034 6480464 Sulindac affects the localization of BAK1 protein CTD PMID:17136320 sulindac multiple interactions ISO RGD:1353034 6480464 SB 203580 inhibits the reaction [Sulindac affects the localization of BAK1 protein] CTD PMID:17136320 sulindac sulfide increases response to substance EXP 6480464 BAK1 results in increased susceptibility to sulindac sulfide CTD PMID:18349538 sulindac sulfone increases response to substance EXP 6480464 BAK1 results in increased susceptibility to sulindac sulfone CTD PMID:18349538 tamibarotene increases expression ISO RGD:1353034 6480464 tamibarotene results in increased expression of BAK1 mRNA CTD PMID:15498508 TEMPO multiple interactions EXP 6480464 TEMPO inhibits the reaction [nickel sulfate results in increased expression of BAK1 mRNA], TEMPO inhibits the reaction [nickel sulfate results in increased expression of BAK1 protein] CTD PMID:28296042 terbufos increases methylation ISO RGD:1353034 6480464 terbufos results in increased methylation of BAK1 promoter CTD PMID:22847954 tert-butyl hydroperoxide decreases expression ISO RGD:1353034 6480464 tert-Butylhydroperoxide results in decreased expression of BAK1 mRNA CTD PMID:12419474 tetrachloromethane multiple interactions EXP 6480464 [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAK1 mRNA CTD PMID:16610055 tetrachloromethane increases expression ISO RGD:1552456 6480464 Carbon Tetrachloride results in increased expression of BAK1 protein CTD PMID:23279844 , PMID:25432964 tetrachloromethane multiple interactions ISO RGD:1552456 6480464 Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BAK1 protein]] more ... CTD PMID:23279844 , PMID:25432964 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BAK1 mRNA CTD PMID:23411599 Thiotepa increases expression ISO RGD:1353034 6480464 Thiotepa results in increased expression of BAK1 protein CTD PMID:10822281 Thiotepa affects expression ISO RGD:1353034 6480464 Thiotepa affects the expression of BAK1 protein CTD PMID:10822281 trichostatin A multiple interactions ISO RGD:1353034 6480464 [perifosine co-treated with trichostatin A] results in decreased expression of BAK1 protein CTD PMID:15781658 trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of BAK1 mRNA CTD PMID:23558232 trimellitic anhydride increases expression ISO RGD:1552456 6480464 trimellitic anhydride results in increased expression of BAK1 mRNA CTD PMID:19042947 Triptolide increases expression ISO RGD:1552456 6480464 triptolide results in increased expression of BAK1 protein CTD PMID:30009776 Triptolide multiple interactions ISO RGD:1552456 6480464 TRP53 gene mutant form inhibits the reaction [triptolide results in increased expression of BAK1 protein] CTD PMID:30009776 Triptolide increases expression EXP 6480464 triptolide results in increased expression of BAK1 protein CTD PMID:30009776 Triptolide multiple interactions EXP 6480464 pifithrin inhibits the reaction [triptolide results in increased expression of BAK1 protein] CTD PMID:30009776 tunicamycin increases activity ISO RGD:1353034 6480464 Tunicamycin results in increased activity of BAK1 protein CTD PMID:17553788 urethane multiple interactions ISO RGD:1552456 6480464 [Urethane co-treated with Freund's Adjuvant] results in increased expression of BAK1 mRNA CTD PMID:12400877 urethane increases expression ISO RGD:1353034 6480464 Urethane results in increased expression of BAK1 mRNA CTD PMID:28818685 ursolic acid increases activity ISO RGD:1353034 6480464 ursolic acid results in increased activity of BAK1 protein CTD PMID:20630652 valproic acid increases expression ISO RGD:1552456 6480464 Valproic Acid results in increased expression of BAK1 mRNA CTD PMID:21427059 valproic acid decreases expression ISO RGD:1552456 6480464 Valproic Acid results in decreased expression of BAK1 mRNA CTD PMID:21427059 veliparib multiple interactions ISO RGD:1353034 6480464 BAK1 protein results in increased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] CTD PMID:18376143 vincristine affects response to substance ISO RGD:1353034 6480464 BAK1 protein affects the susceptibility to Vincristine CTD PMID:22178383 vorinostat multiple interactions ISO RGD:1353034 6480464 [navitoclax co-treated with vorinostat] affects the activity of BAK1 protein more ... CTD PMID:15781658 more ... vorinostat increases expression ISO RGD:1353034 6480464 vorinostat results in increased expression of BAK1 mRNA, vorinostat results in increased expression of BAK1 protein CTD PMID:16144943 , PMID:19509267 vorinostat affects activity ISO RGD:1353034 6480464 vorinostat affects the activity of BAK1 protein CTD PMID:21652541
